EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2015 | $1,019 | | tax credit/rebate |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2009 | $3,090,000 | | tax credit/rebate |
Emergent BioSolutions | Emergent BioSolutions | Maryland | local | 2009 | undisclosed | | grant |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $2,821,980 | | tax increment financing |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $1,796,389 | | tax increment financing |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2013 | $495,000 | | grant |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2014 | $250,000 | | infrastructure assistance |
EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions | Maryland | local | 2014 | $750,000 | | grant/loan hybrid program |
Emergent Biosolutions Inc. | Emergent BioSolutions | Maryland | state | 2014 | $103,503 | | tax credit/rebate |
Emergent BioSolutions Inc. | Emergent BioSolutions | Maryland | state | 2015 | $2,000,000 | | grant/loan hybrid program |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2011 | $17,868 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2012 | $103,503 | | tax credit/rebate |
Emergent Biosolutions Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2018 | $86,355 | | tax credit/rebate |
Emergent Biosolutions Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2020 | $37,509 | | tax credit/rebate |
Emergent Biosolutions Inc. And Subsidiaries | Emergent BioSolutions | Maryland | state | 2022 | $130,702 | | tax credit/rebate |
Emergent Biosolutions, Inc. | Emergent BioSolutions | Maryland | state | 2016 | $53,219 | | tax credit/rebate |
Emergent Biosolutions, Inc. | Emergent BioSolutions | Maryland | state | 2017 | $32,037 | | tax credit/rebate |
Emergent Biosolutions, Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2010 | $19,113 | | tax credit/rebate |
Emergent BioSolutions, Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2009 | $25,247 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2019 | $31,013 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2021 | $55,509 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. | Emergent BioSolutions | Maryland | state | 2005 | $34,357 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. | Emergent BioSolutions | Maryland | state | 2008 | $31,261 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. (FKA Emergent InnunoSolutions, Inc.) | Emergent BioSolutions | Maryland | state | 2007 | $58,921 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $207,108 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $91,754 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2010 | $91,754 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $47,245 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $101,569 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2013 | $62,739 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,367 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,218 | | tax credit/rebate |
Endo Pharmaceuticals | Endo International | Pennsylvania | state | | $462,000 | | tax credit/rebate |
Endo Pharmaceuticals | Endo International | Pennsylvania | state | | $750,000 | | grant |
Endo Pharmaceuticals Valera, Inc. | Endo International | New Jersey | state | 2004 | $86,295 | | grant |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2010 | $16,834 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2011 | $225,955 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2012 | $454,512 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2013 | $973,073 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $1,170,852 | | tax credit/rebate |
Eon Labs, Inc. | Novartis | North Carolina | state | 2013 | $43,359 | | tax credit/rebate |
Epichem, Inc. | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
Epizyme, Inc. | Epizyme | Massachusetts | state | 2013 | $416,500 | | tax credit/rebate |
ETHICON ENDO-SURGERY INC | Johnson & Johnson | New Mexico | state | 2012 | $281,091 | | tax credit/rebate |
ETHICON INC | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2003 | undisclosed | | enterprise zone |
Ethicon, Inc. | Johnson & Johnson | Texas | state | 2019 | undisclosed | | enterprise zone |
Exelixis, Inc. | Exelixis | California | state | 2019 | $3,000,000 | | tax credit/rebate |
Exelixis, Inc. | Exelixis | California | state | 2020 | $7,000,000 | | tax credit/rebate |
FOREST LABORATORIES, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST LABORATORIES, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2012 | $30,451 | | tax credit/rebate; property tax abatement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2013 | $3,462 | | tax credit/rebate; property tax abatement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2014 | $90,408 | | tax credit/rebate |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 1999 | $360,150 | | grant |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 2000 | $990,780 | | grant |
FOREST RESEARCH INSTITUTE, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2011 | $481,489 | | tax credit/rebate |
FOREST RESEARCH INSTITUTE, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2012 | $999,077 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2013 | $369,915 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2013 | $8,044 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2014 | $5,583 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2015 | $3,513 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $3,500,000 | | grant |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,975,500 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,000,000 | | infrastructure assistance |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2008 | $80,172 | | training reimbursement |
Fort Dodge Laboratories, Inc. | Zoetis | Iowa | state | 2007 | $2,617,500 | | enterprise zone |
Foundation Medicine | Roche | Massachusetts | state | 2014 | $1,225,860 | | tax credit/rebate |
Foundation Medicine Inc. | Roche | Massachusetts | state | 2011 | $78,777 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $150,000 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $300,309 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2011 | $37,523 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2012 | $5,602 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2013 | $4,011 | | tax credit/rebate |
G.D. SEARLE & COMPANY | Pfizer | Missouri | state | 2002 | $1,126,728 | | tax credit/rebate |
Genentech | Roche | Oregon | state | 2013 | $227,332 | | property tax abatement |
Genentech Inc | Roche | Oregon | state | 2013 | $3,340,842 | | tax credit/rebate |
Genentech Inc | Roche | Oregon | local | 2023 | $3,134,511 | | property tax abatement |
Genentech USA Inc | Roche | California | state | 2021 | $68,185 | | training reimbursement |
Genentech USA Inc. | Roche | Oregon | state | 2012 | $3,817,197 | | property tax abatement |
Genentech USA, Inc | Roche | Oregon | state | 2019 | $500,260 | | grant |
Genentech USA, Inc | Roche | Oregon | state | 2020 | $1,573,000 | | grant |
Genentech USA, Inc. | Roche | Kentucky | state | 2006 | $2,400,000 | | tax credit/rebate |
GENENTECH, INC. | Roche | California | state | 2007 | $602,758 | | training reimbursement |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
General Nutrition Corporation | Harbin Pharmaceutical Group | Pennsylvania | state | 2016 | $10,187 | | tax credit/rebate |
Genzyme Corporation | Sanofi | Florida | state | 2010 | $524,000 | | tax credit/rebate |
Genzyme Corporation | Sanofi | New Mexico | state | 2008 | $277,372 | | training reimbursement |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2011 | $3,743 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2010 | $1,517 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2007 | $63,676 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2008 | $71,546 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2009 | $66,838 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2010 | $72,840 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $83,248 | | tax credit/rebate |